K
Katerina Zoi
Researcher at Academy of Athens
Publications - 52
Citations - 5257
Katerina Zoi is an academic researcher from Academy of Athens. The author has contributed to research in topics: Uniparental disomy & Atypical chronic myeloid leukemia. The author has an hindex of 22, co-authored 50 publications receiving 4898 citations. Previous affiliations of Katerina Zoi include Foundation for Biomedical Research & University of Southampton.
Papers
More filters
Journal ArticleDOI
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst,Andrew Chase,Andrew Chase,Joannah Score,Joannah Score,Claire Hidalgo-Curtis,Claire Hidalgo-Curtis,Catherine Bryant,Catherine Bryant,Amy V. Jones,Amy V. Jones,Katherine Waghorn,Katherine Waghorn,Katerina Zoi,Fiona M. Ross,Fiona M. Ross,Andreas Reiter,Andreas Hochhaus,Hans G. Drexler,Andrew S Duncombe,Francisco Cervantes,David Oscier,Jacqueline Boultwood,Francis H. Grand,Francis H. Grand,Nicholas C.P. Cross,Nicholas C.P. Cross +26 more
TL;DR: In this article, the finding of homozygous EZH2 mutations in 9 of 12 individuals with 7q acquired uniparental disomy was described, and the mutations resulted in premature chain termination or direct abrogation of histone methyltransferase activity.
Journal ArticleDOI
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
Amy V. Jones,Sebastian Kreil,Katerina Zoi,Katherine Waghorn,Claire Curtis,Lingyan Zhang,Joannah Score,Rachel Seear,Andrew Chase,Francis H. Grand,Helen E. White,Christine Zoi,Dimitris Loukopoulos,Evangelos Terpos,Elisavet-Christine Vervessou,Beate Schultheis,Michael Emig,Thomas Ernst,Eva Lengfelder,Rüdiger Hehlmann,Andreas Hochhaus,David Oscier,Richard T. Silver,Andreas Reiter,Nicholas C.P. Cross +24 more
TL;DR: It is concluded that V617F is widespread in MPDs and detection of this acquired mutation is likely to have a major impact on the way patients with MPD are diagnosed, as well as serving as an obvious target for signal transduction therapy.
Journal ArticleDOI
Mutations and prognosis in primary myelofibrosis
Alessandro M. Vannucchi,Tl Lasho,Paola Guglielmelli,Flavia Biamonte,Animesh Pardanani,Arturo Pereira,Christy Finke,Joannah Score,Naseema Gangat,Carmela Mannarelli,Rp Ketterling,Giada Rotunno,Ra Knudson,Mc Susini,Rr Laborde,Ambra Spolverini,Alessandro Pancrazzi,Lisa Pieri,Rossella Manfredini,Enrico Tagliafico,Roberta Zini,Amy V. Jones,Katerina Zoi,Andreas Reiter,Andrew S Duncombe,Daniela Pietra,Elisa Rumi,Francisco Cervantes,G Barosi,Mario Cazzola,Nc Cross,Ayalew Tefferi +31 more
TL;DR: Mutational profiling for ASXL1, EZH2, SRSF2 and IDH identifies PMF patients who are at risk for premature death or leukemic transformation.
Journal ArticleDOI
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.
Francis H. Grand,Claire Hidalgo-Curtis,Thomas Ernst,Katerina Zoi,Christine Zoi,Carolann McGuire,Sebastian Kreil,Amy V. Jones,Joannah Score,Georgia Metzgeroth,David Oscier,Andrew J. Hall,Christian Brandts,Hubert Serve,Andreas Reiter,Andrew Chase,Nicholas C.P. Cross +16 more
TL;DR: It is concluded that acquired, transforming CBL mutations are a novel and widespread pathogenetic abnormality in morphologically related, clinically aggressive MPNs.
Journal ArticleDOI
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.
Amy V. Jones,Andrew Chase,Richard T. Silver,David Oscier,Katerina Zoi,Y. Lynn Wang,Holger Cario,Heike L. Pahl,Andrew Collins,Andreas Reiter,Francis H. Grand,Nicholas C.P. Cross +11 more
TL;DR: It is reported here that JAK2V617F-associated disease is strongly associated with a specific constitutional Jak2 haplotype, designated 46/1, in all three disease entities compared to healthy controls and provides a model whereby a constitutional genetic factor is associated with an increased risk of acquiring a specific somatic mutation.